Physician profile
Christian N Athanassious
NPI 1043471279
$194,331.45
in general payments reported to CMS, 2019-2025
11 companies · $28K in 2025
The $28K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $9,084 · 2021: $37K · 2022: $15K · 2023: $62K · 2024: $28K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $99K · Travel and Lodging: $14K · Food and Beverage: $4,846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $99,206.00 |
| Travel and Lodging | $13,723.35 |
| Food and Beverage | $4,845.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $136,049.78 | 2019-2023 | Alif, Xlif, Maxcess |
| Globus Medical, INC. | $55,741.09 | 2024-2025 | Alif, Quartex, Maxcess |
| Stryker Corporation | $2,150.52 | 2019-2025 | Pangea |
| Ethicon US, LLC | $90.99 | 2024 | Stratafix, Surgiflo Hemostatic Matrix |
| Depuy Synthes Sales INC. | $76.53 | 2019-2025 | Monovisc |
| Arteriocyte Medical Systems, INC. | $59.05 | 2025 | Magellan |
| Electronic Waveform Lab, INC. | $40.69 | 2019-2022 | |
| Abbott Laboratories | $36.74 | 2022 | |
| Si-Bone, INC. | $34.17 | 2019-2025 | |
| Vertex Pharmaceuticals Incorporated | $27.20 | 2025 | |
| Smith+Nephew, INC. | $24.69 | 2025 | Renasys Touch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Athanassious listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.